Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients
暂无分享,去创建一个
P. Raskin | H. Lebovitz | D. Simonson | P. Johnston | R. Coniff | C. Munera
[1] B. Hoogwerf,et al. Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients , 1994, Diabetes Care.
[2] R. Brodows. Benefits and Risks With Glyburide and Glipizide in Elderly NIDDM Patients , 1992, Diabetes Care.
[3] J. Morley,et al. Unique aspects of diabetes mellitus in the elderly. , 1990, Clinics in geriatric medicine.
[4] B. Naliboff,et al. Effects of Age on Complications in Adult Onset Diabetes , 1989, Journal of the American Geriatrics Society.
[5] J. Morley,et al. Diabetes mellitus in elderly patients. Is it different? , 1987, The American journal of medicine.
[6] K. Minaker,et al. Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levels. , 1987, Journal of gerontology.
[7] L. Lipson. Diabetes in the elderly: diagnosis, pathogenesis, and therapy. , 1986, The American journal of medicine.
[8] R. Lefkowitz,et al. The Impact of Aging on Adrenergic Receptor Function: Clinical and Biochemical Aspects , 1985, Journal of the American Geriatrics Society.
[9] F. Plum,et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. , 1983, The American journal of medicine.
[10] B. Arnetz,et al. The influence of aging on hemoglobin A1c (HbA1c). , 1982, Journal of gerontology.
[11] C. Meinert,et al. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. , 1970, Diabetes.